NeuroBo Pharmaceuticals (NRBO) Institutional Ownership $1.60 -0.16 (-9.09%) (As of 12/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NeuroBo Pharmaceuticals (NASDAQ:NRBO)CurrentInstitutional OwnershipPercentage1.37%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$3.85MNumber ofInstitutional Sellers(last 12 months)0 Get NRBO Insider Trade Alerts Want to know when executives and insiders are buying or selling NeuroBo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRBO Institutional Buying and Selling by Quarter Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. NeuroBo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/6/2024 Ferguson Wellman Capital Management Inc.15,670$50K0.0%N/A0.191% 8/15/2024 Armistice Capital LLC696,829$3.37M0.0%N/A14.204% 8/15/2024 Affinity Asset Advisors LLC89,222$432K0.0%N/A1.819% 2/14/2022 Murchinson Ltd.205,256$251K0.0%N/A0.772% 11/9/2021BlackRock Inc.44,579$166K0.0%-11.3%0.200% 9/3/2021Parametric Portfolio Associates LLC16,530$55K0.0%N/A0.074% 8/16/2021 State Street Corp15,878$53K0.0%-78.6%0.071% 8/13/2021 Northern Trust Corp24,579$82K0.0%-68.9%0.110% 8/13/2021 Vanguard Group Inc.477,918$1.59M0.0%-30.2%2.145% 8/12/2021 Advisory Services Network LLC8,550$28K0.0%N/A0.038% 8/12/2021Ergoteles LLC30,800$103K0.0%N/A0.138% 8/11/2021 Deutsche Bank AG31,090$104K0.0%+1,016.3%0.140% 8/4/2021 Mount Yale Investment Advisors LLC57,425$191K0.0%N/A0.258% 5/18/2021 California State Teachers Retirement System9,817$43K0.0%+52.1%0.044% 5/17/2021 Goldman Sachs Group Inc.10,056$44K0.0%N/A0.045% 5/13/2021 Bank of New York Mellon Corp19,178$84K0.0%N/A0.087% 5/12/2021 JPMorgan Chase & Co.18,449$81K0.0%+69.4%0.083% 5/7/2021BlackRock Inc.226,013$995K0.0%+2.7%1.019% 2/19/2021 JPMorgan Chase & Co.10,889$57K0.0%+234.8%0.055% 2/11/2021 Northern Trust Corp80,860$425K0.0%-5.4%0.411% 2/9/2021 Wells Fargo & Company MN17,562$92K0.0%+1,213.5%0.089% 2/5/2021BlackRock Inc.219,989$1.15M0.0%+5.0%1.339% 11/10/2020 State Street Corp41,439$233K0.0%+7.3%0.252% (Data available from 1/1/2016 forward) NRBO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRBO shares? During the previous two years, the following institutional investors and hedge funds held shares of NeuroBo Pharmaceuticals shares: Armistice Capital LLC ($3.37M), and Affinity Asset Advisors LLC ($432K), Ferguson Wellman Capital Management Inc. ($50K).Learn more on NRBO's institutional investors. What percentage of NeuroBo Pharmaceuticals stock is owned by institutional investors? 1.37% of NeuroBo Pharmaceuticals stock is owned by institutional investors. Learn more on NRBO's institutional investor holdings. Which institutional investors have been buying NeuroBo Pharmaceuticals stock? The following institutional investors have purchased NeuroBo Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($696.83K), Affinity Asset Advisors LLC ($89.22K), and Ferguson Wellman Capital Management Inc. ($15.67K). How much institutional buying is happening at NeuroBo Pharmaceuticals? Institutional investors have bought a total of 801,721 shares in the last 24 months. This purchase volume represents approximately $3.85M in transactions. Related Companies Ovid Therapeutics Major Shareholders FibroBiologics Major Shareholders Aerovate Therapeutics Major Shareholders ESSA Pharma Major Shareholders Unicycive Therapeutics Major Shareholders PDS Biotechnology Major Shareholders Annovis Bio Major Shareholders Theratechnologies Major Shareholders Repare Therapeutics Major Shareholders Vistagen Therapeutics Major Shareholders This page (NASDAQ:NRBO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRBO Stock Alerts